JD Health Limited issued 1,000,000 new ordinary shares on August 21, 2024, in accordance with its stock incentive plan following the initial public offering on November 23, 2020, accounting for 0.03% of its existing issued shares. Following this share issuance, the total number of issued shares of the company increased from 3,189,465,111 shares to 3,190,465,111 shares. The company has confirmed that all related share issuances or sales of treasury shares have been formally authorized and approved by the board of directors, and comply with all applicable listing rules, laws, and other regulatory requirements. On the same day, Director Jin Enlin submitted the relevant documents.

JD Health Limited issued 1,000,000 new ordinary shares on August 21, 2024, in accordance with its stock incentive plan following the initial public offering on November 23, 2020, accounting for 0.03% of its existing issued shares. Following this share issuance, the total number of issued shares of the company increased from 3,189,465,111 shares to 3,190,465,111 shares. The company has confirmed that all related share issuances or sales of treasury shares have been formally authorized and approved by the board of directors, and comply with all applicable listing rules, laws, and other regulatory requirements. On the same day, Director Jin Enlin submitted the relevant documents.